Literature DB >> 25824401

Mind the gap! Lay and medical perceptions of risks associated with the use of alternative treatment and conventional medicine.

Anita Salamonsen1.   

Abstract

BACKGROUND: Studies on the widespread use of complementary and alternative medicine (CAM) demonstrate that CAM users base their treatment decisions on both subjective, experience-based knowledge and medical knowledge. The aim of this study was to explore lay and medical risk perceptions associated with CAM and conventional medicine. PATIENTS AND METHODS: In this explorative qualitative study, we conducted in-depth interviews with 25 Norwegian CAM users with cancer or multiple sclerosis and 12 doctors.
RESULTS: The interviews revealed fundamental differences in risk perceptions influencing treatment decisions and risk communication in a clinical setting. While CAM users considered conventional medicine as potentially risky and related this to experiences of severe adverse effects, CAM was perceived as natural and safe. Doctors' risk perceptions were quite the contrary, mainly because of lack of scientific evidence for CAM as a safe and beneficial treatment option.
CONCLUSION: For the safety of CAM users, such divergent risk perceptions may have far-reaching consequences. CAM users should be taken seriously with their self-perception as decision-makers considering their approaches to experiences, knowledge, and science. An awareness of differing lay and medical risk perceptions associated with CAM and conventional medicine in research, doctor-patient communication, and education of patients and doctors is thus important to optimize patient safety in complex health care systems.
© 2015 S. Karger GmbH, Freiburg.

Entities:  

Mesh:

Year:  2015        PMID: 25824401     DOI: 10.1159/000376555

Source DB:  PubMed          Journal:  Forsch Komplementmed        ISSN: 1661-4119


  8 in total

Review 1.  Herbal Nephropathy.

Authors:  Amita Jain; Juan Jose Olivero
Journal:  Methodist Debakey Cardiovasc J       Date:  2019 Jul-Sep

Review 2.  Perception of risk and communication among conventional and complementary health care providers involving cancer patients' use of complementary therapies: a literature review.

Authors:  Trine Stub; Sara A Quandt; Thomas A Arcury; Joanne C Sandberg; Agnete E Kristoffersen; Frauke Musial; Anita Salamonsen
Journal:  BMC Complement Altern Med       Date:  2016-09-08       Impact factor: 3.659

3.  Which risk understandings can be derived from the current disharmonized regulation of complementary and alternative medicine in Europe?

Authors:  Solveig Wiesener; Anita Salamonsen; Vinjar Fønnebø
Journal:  BMC Complement Altern Med       Date:  2018-01-10       Impact factor: 3.659

4.  Complementary medicine use during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre.

Authors:  Mégane Jermini; Julie Dubois; Pierre-Yves Rodondi; Khalil Zaman; Thierry Buclin; Chantal Csajka; Angela Orcurto; Laura E Rothuizen
Journal:  Sci Rep       Date:  2019-03-25       Impact factor: 4.379

5.  Fear, fight, familiarize: the experiences of people living with relapsing-remitting multiple sclerosis and taking oral medication.

Authors:  Eva Van Reenen; Wieke Van Der Borg; Merel Visse; Hanneke Van Der Meide; Leo Visser
Journal:  Int J Qual Stud Health Well-being       Date:  2019-12

6.  Potential factors that influence usage of complementary and alternative medicine worldwide: a systematic review.

Authors:  Mayuree Tangkiatkumjai; Helen Boardman; Dawn-Marie Walker
Journal:  BMC Complement Med Ther       Date:  2020-11-23

7.  Patient-based benefit-risk assessment of medicines: development, refinement, and validation of a content search strategy to retrieve relevant studies.

Authors:  Hiba El Masri; Treasure M McGuire; Christine Dalais; Mieke van Driel; Helen Benham; Samantha A Hollingworth
Journal:  J Med Libr Assoc       Date:  2022-04-01

Review 8.  Mapping the risk perception and communication gap between different professions of healthcare providers in cancer care: a cross-sectional protocol.

Authors:  Trine Stub; Frauke Musial; Sara A Quandt; Thomas A Arcury; Anita Salamonsen; Agnete Kristoffersen; Gro Berntsen
Journal:  BMJ Open       Date:  2015-09-03       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.